Correlation Between Protagonist Therapeutics and Viridian Therapeutics

Can any of the company-specific risk be diversified away by investing in both Protagonist Therapeutics and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagonist Therapeutics and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Protagonist Therapeutics and Viridian Therapeutics, you can compare the effects of market volatilities on Protagonist Therapeutics and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagonist Therapeutics with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagonist Therapeutics and Viridian Therapeutics.

Diversification Opportunities for Protagonist Therapeutics and Viridian Therapeutics

0.6

Correlation Coefficient

Protagonist Therapeutics  Viridian Therapeutics

Poor diversification

The 3 months correlation between Protagonist and Viridian is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Protagonist Therapeutics and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and Protagonist Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagonist Therapeutics are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of Protagonist Therapeutics i.e., Protagonist Therapeutics and Viridian Therapeutics go up and down completely randomly.

Pair Corralation between Protagonist Therapeutics and Viridian Therapeutics

Given the investment horizon of 90 days Protagonist Therapeutics is expected to generate 1.05 times more return on investment than Viridian Therapeutics. However, Protagonist Therapeutics is 1.05 times more volatile than Viridian Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Viridian Therapeutics is currently generating about 0.0 per unit of risk. If you would invest  1,134  in Protagonist Therapeutics on August 31, 2024 and sell it today you would earn a total of  3,361  from holding Protagonist Therapeutics or generate 296.38% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Protagonist Therapeutics  vs.  Viridian Therapeutics

Protagonist Therapeutics

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Protagonist Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady technical and fundamental indicators, Protagonist Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Viridian Therapeutics

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Viridian Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting fundamental indicators, Viridian Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Protagonist Therapeutics and Viridian Therapeutics

The main advantage of trading using opposite Protagonist Therapeutics and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagonist Therapeutics position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.

The idea behind Protagonist Therapeutics and Viridian Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.